J. Oliver

发表

Involvement of poly(ADP-ribose) polymerase in base excision repair.

V. Schreiber, J. Ménissier-de murcia, G. de Murcia, 1999, Biochimie.

Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction.

M. García-Aranda, E. Alba, I. Barragán, 2021, Seminars in cancer biology.

Liquid Biopsy as a Tool for the Characterisation and Early Detection of the Field Cancerization Effect in Patients with Oral Cavity Carcinoma

I. Barragán, E. Pérez-Ruiz, J. Oliver, 2021, Biomedicines.

Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma

E. Alba, M. Cobo, I. Barragán, 2022, Biomedicines.

Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition

M. Queipo-Ortuño, I. Barragán, E. Pérez-Ruiz, 2022, International journal of molecular sciences.

2 PARP inhibitors: New partners in the therapy of cancer and inflammatory diseases

R. Aguilar-Quesada, J. Linares, M. I. Rodríguez, 2009 .

High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade

E. Alba, C. D. de Andrea, M. Cobo, 2022, International journal of molecular sciences.

Preclinical models in head and neck squamous cell carcinoma

I. Barragán, E. Pérez-Ruiz, J. Oliver, 2023, British Journal of Cancer.

Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors

F. Rojo, J. Yélamos, J. Albanell, 2016, Oncoimmunology.

O IV.4 Poly(ADP-ribose) polymerase interacts with the base excision repair factor XRCC1 and is required in recovery from DNA damage in mice and in cells

P. Chambon, B. Dutrillaux, A. Dierich, 1997 .

Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade

I. Barragán, E. Pérez-Ruiz, J. Oliver, 2023, Cancers.